Pioneera Biosciences disrupts next-generation immune therapies through its immune orchestration platform
Pioneera Biosciences has raised $5.3M in total funding. The most recent round was Seed. The last funding was announced in February 2026.
Pioneera Biosciences's investors include Plug and Play, Prepare.
Pioneera Biosciences is headquartered in Vilnius, Lithuania.
Pioneera Biosciences disrupts next-generation immune therapies through its immune orchestration platform
Pioneera Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pioneera Biosciences — Funding & Investors." VCBacked, February 1, 2026, https://www.vcbacked.co/company/pioneera-biosciences. Accessed September 30, 2026.
VCBacked. (2026). Pioneera Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/pioneera-biosciences
{{cite web |title=Pioneera Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/pioneera-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated